BUSINESS COMBINATIONS - Pro Forma Information (Details) - GeneSiC - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Revenue	$ 48,615	$ 38,145
Net income (loss)	$ 72,279	$ (162,744)
Basic net income (loss) per share (in dollars per share)	$ 0.54	$ (2.54)
Diluted net income (loss) per share (in dollars per share)	$ 0.50	$ (2.54)